⚙
AI-generated deep summary
by claude@2026-06, 2026-06-24
· read from full text
ⓘ
The study developed an unsupervised deep learning framework for large-scale cardiotoxicity screening using high-throughput calcium transient recordings from hiPSC-derived cardiomyocytes across five donors. Using data from 1,029 compounds tested in concentration-response, the authors trained an autoencoder on baseline signals to quantify drug/chemical-induced functional perturbations via reconstruction error, then generated effect levels and aggregated donor-specific scores to assess inter-individual variability. They reported substantial variability in cardiotoxicity potential across donors, while microbiocides, dyes, and pesticides showed high toxicity scores with low variability. The paper does not detail any explicit clinical validation or direct comparison to established cardiotoxicity assays, which limits interpretation of real-world risk. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.
Abstract
Cardiotoxicity remains a major cause of drug attrition and post-market withdrawal, yet the vast majority of environmental chemicals to which humans may be exposed remain uncharacterized for cardiotoxicity risk. Human induced pluripotent stem cell (hiPSC)-based testing has been proposed to address this gap. Here we present an unsupervised deep learning framework for multi-donor cardiotoxicity screening using high-throughput calcium transient recordings from hiPSC-derived cardiomyocytes (hiPSC-CMs). We used data from a library of 1,029 compounds that were tested in hiPSC-CM from five donors in concentration-response. An autoencoder trained exclusively on baseline signals quantified chemical-induced functional perturbations through reconstruction error, bypassing the need for labeled training data while capturing the full spectrum of calcium handling disruptions. Using this framework, we generated effect levels. Aggregation of donor-specific scores revealed substantial inter-individual variability in potential cardiotoxicity, underscoring the value of this approach for population-level risk prediction. We found that microbiocides, dyes, and pesticides to have potential concern, characterized by high toxicity scores and low inter-donor variability. This framework establishes a scalable, human-relevant, and genetically diverse platform for cardiotoxicity surveillance across both pharmacological and environmental chemical spaces, with direct implications for drug and chemical safety evaluation and prioritization for additional studies.
Full text
1,642 characters
· extracted from
oa-doi-fallback
· click to expand
Abstract
Cardiotoxicity remains a major cause of drug attrition and post-market withdrawal, yet the vast majority of environmental chemicals to which humans may be exposed remain uncharacterized for cardiotoxicity risk. Human induced pluripotent stem cell (hiPSC)-based testing has been proposed to address this gap. Here we present an unsupervised deep learning framework for multi-donor cardiotoxicity screening using high-throughput calcium transient recordings from hiPSC-derived cardiomyocytes (hiPSC-CMs). We used data from a library of 1,029 compounds that were tested in hiPSC-CM from five donors in concentration-response. An autoencoder trained exclusively on baseline signals quantified chemical-induced functional perturbations through reconstruction error, bypassing the need for labeled training data while capturing the full spectrum of calcium handling disruptions. Using this framework, we generated effect levels. Aggregation of donor-specific scores revealed substantial inter-individual variability in potential cardiotoxicity, underscoring the value of this approach for population-level risk prediction. We found that microbiocides, dyes, and pesticides to have potential concern, characterized by high toxicity scores and low inter-donor variability. This framework establishes a scalable, human-relevant, and genetically diverse platform for cardiotoxicity surveillance across both pharmacological and environmental chemical spaces, with direct implications for drug and chemical safety evaluation and prioritization for additional studies.
Competing Interest Statement
The authors have declared no competing interest.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.